Michael J. Weber (August 23, 1942 – February 11, 2021) was an American research scientist, former director of the University of Virginia Cancer Center and the Weaver Professor of Microbiology, Immunology and Cancer Biology in the University of Virginia School of Medicine.
[1] He was a co-discoverer of Mitogen-activated protein kinase, publishing a widely cited paper on the topic in 1989.
[2][3] He also contributed to the development of ibrutinib and venetoclax combination therapy for Non-Hodgkin's lymphoma.
His successor as Cancer Center Director, Thomas P. Loughran Jr., called him the "heart and soul" of the cancer center,[5] and noted that Weber was known for being actively invested in the success of his numerous students, post-doctoral fellows, and employees.
The University of Virginia School of Medicine established an annual symposium in Weber's honor.